Leadership

 

 

President

Seth J. Baum, MD, FASPC

Dr. Seth J. Baum, a graduate of Columbia College and Columbia College of Physicians and Surgeons, completed training in Internal Medicine, Cardiology, Interventional Cardiology, and Electrophysiology.  He has directed and founded multiple Cardiac Catheterization and Electrophysiology laboratories.  Dr. Baum has worked extensively in Integrative Cardiology, directing the Boca Raton division of Harvard’s Mind/Body Medicine Institute.

Dr. Baum is a fellow of the American College of Cardiology, the American Heart Association, the American College of Preventive Medicine, the National Lipid Association, and the American Society for Preventive Cardiology. He is a Founding Physician/Scientist Member of the Society for Cardiovascular CT and is board certified in Cardiovascular CT. Dr. Baum served as treasurer of the International Society for the Study of Fatty Acids and Lipids. He founded and directs the Women’s Preventive Cardiology program at Boca Raton Regional Hospital. He is the President of the American Society for Preventive Cardiology (ASPC). Annually, Dr. Baum chairs the ASPC’s Conference on CVD Prevention. Dr. Baum is the Secretary/Treasurer of the Board of Directors of the FH Foundation. He sits on the American Heart Association’s Council for Epidemiology and Prevention, the Interdisciplinary Council for Prevention, and the Prevention Science Committee. He has written numerous peer reviewed papers as well as two books, The Total Guide to a Healthy Heart, and Age Strong, Live Long; Lessons from my Patients. In 2013 he was awarded Cleveland Heart Lab’s “Heart Award” for lifelong dedication to Preventive Medicine. Dr. Baum is the Founder and Chief Medical Officer of Excel Medical Clinical Trials, LLC, a consortium of clinicians dedicated to the safe and professional conduct of high-level scientific trials.

Associate Affiliate Professor of Medicine at FAU Medical School, Dr. Baum has a practice in Boca Raton, Florida that is devoted solely to Clinical Lipidology - he is board certified by the American Board of Clinical Lipidology - and Cardiovascular Disease Prevention. Dr. Baum also founded and directs the only lipoprotein apheresis program in southeast Florida. He lectures both nationally and internationally, emphasizing Familial Hypercholesterolemia, ASCVD prevention, lipid disorders and evolving therapies, Integrative Cardiology, sex distinctions in CVD, and omega-3 fatty acids.


President-Elect

Amit Khera, MD, FASPC

Amit Khera MD, MSc, FASPC, FACC is an Associate Professor of Medicine at the University of Texas, Southwestern Medical School in Dallas, Texas where he serves as Director of the Preventive Cardiology Program and Program Director for the Cardiology Fellowship, and holder of the Dallas Heart Ball Chair in Hypertension and Heart Disease. He is also Medical Director of Cardiac Rehabilitation at University Hospital-St.Paul and Parkland Memorial Hospital. His research interests include the primary and secondary prevention of coronary artery disease, focusing on risk assessment and risk factor modification in those with premature and familial disease. Dr. Khera received his undergraduate degree in American History from the University of Pennsylvania, with magna cum laude honors. He obtained his medical degree from Baylor College of Medicine where he served as class president and was inducted into the Alpha Omega Alpha honor medical society. He completed an Internal Medicine Residency at Brigham and Women’s Hospital, Harvard Medical School, followed by a Cardiology Fellowship at the University of Texas, Southwestern Medical Center. He also completed his Masters degree in Epidemiology at the Harvard School of Public Health.


Treasurer

Howard Weintraub, MD, FASPC

Howard Weintraub, MD, FASPC is a Clinical Professor at the Department of Medicine at NYU Lipid Group in New York City. He is Board Certified in Ab Internal Medicine and Cardiovascular Disease.

Dr. Weintraub is a graduate of New York University of Medicine, as well as a Graduate of NYU Medical Center (Medicine) where he completed his residency training.He also completed his clinical fellowships at NYU Medical Center in Pulmonary Diseases and Cardiology.

During his career, Dr. Weintraub has written and co-authored many publications including "Treatment of multiple-risk patients: using combination therapy to treat beyond LDL lowering" and "A Current Approach to Statin Intolerance".


Secretary

Peter P. Toth, MD, FASPC

Dr. Toth received his B.A. in Biochemistry from Princeton University and a Ph.D. in Biochemistry from Michigan State University. He graduated from Wayne State University School of Medicine and completed residency training in Family Medicine at the University of Iowa Hospitals and Clinics. He is a member of Alpha Omega Alpha and Sigma Xi, and is a past President of the National Lipid Association. Dr. Toth is President of the American Board of Clinical Lipidology and a member of the board of the American Society of Preventive Cardiology.

Dr. Toth has authored and coauthored over four hundred publications in medical and scientific journals and textbooks. He is Editor-in-Chief of the Year in Lipid Disorders (Atlas Publishing, Oxford, UK) and an Associate Editor for the Year Book of Endocrinology (Elsevier, New York). He is coeditor of nine textbooks, including the Family Practice Handbook, Comprehensive Management of High Risk Cardiovascular Patients, Therapeutic Lipidology, Current Controversies in Dyslipidemia Management, Practical Lipid Management, Comprehensive Cardiovascular Care in the Primary Care Setting, Clinical Challenges in Hypertension vols I and II, Cardiac Lipoglucotoxicity, Lipoproteins in Diabetes Mellitus. He has lectured on many topics in cardiovascular medicine throughout the world.


Laurence Sperling

Immediate Past President

Laurence S. Sperling, MD, FASPC

Laurence S. Sperling, MD, FASPC, FACC, FAHA, FACP is the Founder and Director of Preventive Cardiology at the Emory Clinic and Co-Director of the Cardiovascular Disease Fellowship Program at Emory. He is currently Professor of Medicine (Cardiology) at the Emory University School of Medicine. He was awarded The American College of Cardiology Harry B. Graf Career Development Award for Heart Disease Prevention and The American Heart Association Council on Clinical Cardiology Scholarship for Physical Activity and Public Health in 2001.

Dr. Sperling is originally from New York. He received his undergraduate degree from Emory College where he was accepted into Emory University School of Medicine's Early Acceptance Program as a college sophomore. He graduated with his M.D. in 1989, and subsequently completed 8 additional years of training at Emory including a residency in internal medicine, chief resident year at Emory University Hospital, an NIH-supported research fellowship in molecular and vascular medicine, and a clinical fellowship in cardiovascular diseases.

Dr. Sperling serves or has served as medical director for a number of unique programs at Emory including The HeartWise Risk Reduction Program, InterVent Atlanta, Staying Aloft, and has served as special consultant to The Centers for Disease Control. He founded (in 2004) and directs the first and only LDL apheresis program in the state of Georgia. He has been voted one of America's and Atlanta's Top Doctors and appeared often on local and national TV, newspaper, radio, and magazines. In 2011 he was chosen as one of 22 national dietary experts by U.S. News and World Report to evaluate and rank America's popular diets. He has received awards for excellence in both teaching (including 3 Golden Apple Awards and The Dean's Teaching Award) and mentorship. He was chosen by the Dean at Emory University School of Medicine to be among the first faculty society advisors for the school's new curriculum. He had served as Associate Director of the Cardiovascular Fellowship Training program at Emory for over a decade. He has been an investigator in a number of important clinical trials including JUPITER, COURAGE, and BARI-2D and has authored over 100 manuscripts, abstracts, and book chapters. He is co-editor of the American College of Cardiology's Diabetes Self Assessment Program.

Dr. Sperling has been a marathon runner having completed the New York, Prague, and Atlanta marathons. In 2010 he ran the original course from Marathon to Athens, Greece to celebrate the 2500th anniversary of this event. He lives in the Druid Hills neighborhood of Atlanta with his wife, Sidney, and 2 sons, Mathew and Daniel.

 


At Large Directors

Term Expiring 2017

Martha Gulati, MD, FASPC
Columbus, OH

John M. Miles, MD, FASPC
Rochester, MN

Michael D. Shapiro, MD, FASPC
Portland, OR

James A. Underberg, MD, MS, FASPC
New York, NY


Term Expiring 2018
Alan S. Brown, MD, FASPC
Park Ridge, IL 

Mahfouz El Shahawy, MD, MS, FASPC
Sarasota, FL

Pamela B. Morris, MD, FASPC
Charleston, SC

 


Term Expiring 2019
Sergio Fazio, PhD
Portland, OR

Yehuda Handelsman, MD
Tarzana, CA

Nathan Wong, PhD, FASPC
Irvine, CA